【Molecular composition】：

【CAS】：641571-10-0

【source】：Nilotinib

【Certification】：

【Spec】：Anhydrate/Monohydrate/Dihydrate/Free Base

【DMF】：Available

【use】：

Nilotinib is indicated for the treatment of chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (CML) in adult patients resistant or intolerant to prior therapy that included imatinib.